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Introduction
As inan\ as I 502. of communit —dwelling elderls Americans suffer
from depressive sy mptoins and I —301 sufferfrom majordepression.
Tricyclic antidepressants are effective in the management of depres
sion. however, their anticholinergic. alpha—I —adreneruic. and anti
histamine effects limit their utility in manx elderl patients. The
selective serotonin reuptake inhibitors (SSRIs) have increasingly
become the first-line therapy for depression because of their seroto
nm specificity. The are less likely tocause orthostatic hvpotension.
urinary hesitancy, and anticholinergic side effects, however. the
commonly cause gastrointestinal upset and sexual dysfunction.
In the elderly, there has been an association between the S SRIs
and the syndrome of inappropriate antidiuretic hormone secretion
(SIADH a rare but potentially fatal adxerse effect. Until recently,
the incidence and risk factors for the development of SSRI—induced
SIADH among the elderly was unkno n. In a retrospective case
control study of outpatients and inpatients in a rehabilitation service
over the age of 65 who had been taking either fluoxetirie or
paroxetine. the incidence of h ponatremia was estimated to be I in
200 per year. A statistically significant loer bod’s ‘s eight ‘s’sas
observed between cases (mean 530 kg, 95% Cl 46.5-59.5 kg) and
controls mean 64.5 kg. 95ct Cl 60.1-68.4 kg. There was no
statistically significant difference in age between the groups and the
mean time to develop hyponatremia was 18 days (range 4-64 days).
In another retrospective study of elderly patients admitted to an
acute psychiatry ward who were giscn an SSRI in32 . 25ct
dc’s eloped hy ponatremia, halt of these ‘a crc s mptomatic. including
one patient who died following status epilepticus.3 These data,
although limited by their small sample si/C. suggest that the inci
dence of hponatrcmia in elderly patients on SSRIs P low among
outpatients but ma he higher among those requiring hospitalitation
for acute psychiatric management.
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The diagnosis of SIADH induced b\ an SSRI should he made ‘s’s ith
the appropriate laboratory data and exclusion of other causes of
SIADFI (i.e. diseases of the pulmonar . nervous, renal. and endo
crine organ systems. malisnane .and other medications) Although
many case reports describe the relationship between SIADH and
SSRIs. few report the effect of a rechallenge with an SSRI. We
present a case of an elderI patient ‘s’s ho dc’s eloped hvponatreinia
‘a hile on sertrahne and SIADH when rechallenged with tluoxetirie.
Case Report
A 94 ‘sear old man ‘a as diagnosed with major depressive disorder in
August 1999 and was started on sertraline. His past medical history
‘s’s as significant for hypertension and unilateral suprac lavicularfossa
neurohhroma. His other medications included atenolol. nifedipine.
and valsartan. Two months later, he complained of weakness and
persistence of depressive symptoms A serum sodium level at that
time ‘a as 122 meq/L. his baseline sodium level had been between
132—140 meq/L over the past three ‘sears. Sertraline ‘a as discontin
ued because of hyponatremia. He returned in February 2000 with a
complaint of poor appetite and fatigue . .Serum sodium ‘a as 126 meq/
L. He agreed to rechallenge with fluoxetine. One month later he
complained of polydipsia, estimated to be 2-3 liters per day. He
denied polvuria. polvphagia. weakness, lethargy. muscle cramps. or
seizure. Ph shoal examination was significant for weight of 46.8 kg
and climcal euvolemia. Serum sodium was 114 meqlL. He was
admitted to the hospital for evaluation and management of hy
ponatremia.
S1ADH ‘a as suspected and confirmed b laboratory testing (Table
H. Workup ofSIADH includedTSH, PSA, mortiing serum cortisol.
cosvntropin stimulation test. fecal occult blood testing, chest x-ray.
head CT. and renal ultrasound. All ‘acre within normal limits.
Treatment began with fluid restriction (800 cc/day), infusion ot 3%
saline, and cessation of fluoxetine, Hypertonic saline was stopped
‘s’s hen the sodium corrected to 122 meq/L the following day. Sodium
chloride tablets I gm tid were then started and fluid restriction
continued. On hospital day 6, sodium was 128 meq/L at which point
Iluoxetine ‘s’sas restarted, At -discharge on hospital day 8. sodium
corn’c tedto I 3OmeqiL. He was discharged ‘a ith instructions to- limit
fluid intake to I 000cc/day, sodium chloride tablets I mg tid, tluoxetine
It) my qd, and niledipine, ‘s alsartan. and atenolol as prior to admnis—
smn, Serum sodium was I 30 meqiL four days after discharge.
Table 1
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In July 2000. he presented for follow—up and complained of
latigue and irritable mood. He admitted to noncompliance with
sodium chloride supplementation. In the interval since discharge.
serum sodium had remained stable and his mood gradually im
proved. Serum sodium was 1 20 meq/L and he was admitted for
management of hyponatrernia. He was placed on fluid restriction.
sodium chloride tablets as prior to admission, and fluoxetine was
discontinued. L rine sodium was 97 meq/L and urine osmolalitv was
41 7 mosmjkg, At discharge on hospital day 4. serum sodium
improved to 129 meq/L. He was restarted on fluoxetine It) mc per
da . w aterrectriction. and sodium chloride tablets. At follow —up one
week later he reported improved mood and serum sodium was 13 I
meq/L.
Discussion
This elderly man developed hvponatremia sn ith sertraline and when
rechallenged with fluoxetine developed SIADH. With both sertralinc
and tluoxetine. depressi e s’ mptoins failed to improve at two
months and one month. respectively. The temporal relationship
hetw ecu sertraline and hvponatremia and between fluoxetine and
SIADH with a negative w orkup for an organic cause of SIADH
suggested that this was due to the SSRIs. Of interest is that four
months after stopping sertraline, hyponatremia had not completely
corrected. The reason for this remains unclear, In addition, his
weight was in the range that placed him at risk for the den elopment
of hyponatremia. and he developed it within the period noted in the
sttid mentioned earl icr.:
Therap with fltioxetine and outpatient management of SIADH
after his first hospitalization resulted in clinical improvement in
depressive svnlptoms for this patient, the first time since taking an
SSRI .A regimen of water restriction and sodium replacement
maintained normal sodium levels until he became noncompliant
with the sodium supplements. Depressive s mptoms also returned
with this episode of hnponatremia. Reinstituting sodium supple
mentation led to unproved mood again and allowed the patient to
cominue with fluoxetine therapy.
Conclusion
SIADH is a rare and potentially fatal adverse effect of the SSRIs. It
should be suspected when a patient fails to respond to an SSRI. have
other symptoms of hvponatremia. or are noted to have asvmptom—
atic hyponatremia. In this elderly man who developed hyponatre
mia with sertraline and SIADH with fluoxetine, he failed to show an
improvement in depressive symptoms with either SSRI. A regimen
of fluoxetinc. water restriction, and sodium supplementation sue—
cessfull improved his mood while maintaining a stable serum
sodium level.
Authors
5Kalani Raphael MS1V. Liniversitn of Hawau John A. Burns School
of Medicine.
tm5Jinichi Tokeshi MD. Associate Clinical Professor, University of
Hawaii John A. Burns School of Medicine.
References
If B C_i’ tf:’ ‘-
60 5cc’ 20 9-’
2 W:knsonTJ BeccEJ.W’nte’AC S rvb’P c’decea7dr’nk’ac1D’cycona1rae”avr’o’,nno
trearme’lwri’ :doxetrneorpsrcxevne ineider:vpecce Br,1shjouma c’Cin:cai Pnarmacc’cgy ‘999:
47:211-
3. Bouman WP, Pinner G, Johnson H. Incidence of selective serotonin reuptake inhibitor induced
hyponatraemia due to the syndrome of inappropriate antidiuretic horm.one secretion in the elderly.
international Journal of Geriathc Prychiatry 1998: 3:12-15,
4. Strachan J. Shepherd J. Hyponatraemra assccarec w1h the use of selective serotoan re-uptake
rnt9bitos AustraJan and New Zealand Journai of Pnych:atry 1998 32’ 295-98.
5. WooMH. Smythe MA. Assocaton of S:ADH with se’ectve sero:or’ ‘euprake 9701cm Tm Annas
P9arr’ac’otn.e’acv 997. 3’ ‘28-10.
6. MicrO. Hyoonatrema: Age-reareo 6sk1actors ano Inerapu decisions Ger:al’cs 1998.53 32.48.
‘C HwanCA5 Maa’awRM. Syndromeofinacoroprialesecreho’otart;orurecho’rroneouelotLcetne.
Arvei’car joLrnaio Pny’ch.’st’i 1989, 146’ 399
8 9droo.m NJ. Macas NE. Hyposat’em a New E7giand Jssrnai e Medicine 2000: 342, 1581-89.
9 Burke D. Faneer S. Fluosefise and the syndrome of inappropriate secretion of antidiurstic hormone.
Australian and New Zealano Journal of Psychiatry 1996: 30: 295-98.
10. Liv BA. Mit:mann N. Knowles SR. Shear NH. Hypsnalremia and the syndrome of :napproprlate
secretion of antidiuretic hormone associated with the use of selective serotonin reuptake inhibitors: a
review of sponatneoss reports Can Med Assoc J 1996:155:519-27.
Until there’s a cure, there’s the American Diabetes Association.
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